Previous 10 | Next 10 |
home / stock / cvs / cvs articles
CVS Health Corp (NYSE: CVS) announced a new approach called CVS 'CostVantage' that evolves the traditional pharmacy reimbursement mode...
The U.S. Supreme Court is reviewing a contentious bankruptcy settlement involving Purdue Pharma, the maker of OxyContin, and its owners, the&n...
CVS Health Corporation (NYSE: CVS) shares are trading lower on Wednesday. The stock may be sinking in response to the reported discussions between ...
Amazon.Com, Inc. (NASDAQ: AMZN) has received a warning from the U.S. Food and Drug Administration for selling and distributing certa...
In the current market session, CVS Health Inc. (NYSE:CVS) price is at $66.95, after a 0.31% increase. However, over the past month, the stock decre...
Although U.S. stocks closed slightly higher on Monday, there were a few notable insider trades. When insiders purchase shares, it indicates their c...
In a recent surge of labor unrest, pharmacy employees from CVS Health Corporation (NYSE: CVS) and Walgreens Boots Alliance, Inc. (NASDAQ: WBA) rais...
Stocks experienced a modest surge amid the Federal Open Market Committee meeting Wednesday. The central bank is widely expected to leave interest r...
CVS Health Corp's (NYSE: CVS) Q3 sales increased 10.6% Y/Y to $89.76 billion, beating the consensus of $88.25 billion, driv...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, July 15, 2024 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of all persons and entities who purchased securities of CVS Health Corporat...
CVS Health to hold second quarter 2024 earnings conference call PR Newswire WOONSOCKET, R.I. , July 8, 2024 /PRNewswire/ -- CVS Health (NYSE: CVS) will hold a conference call with analysts and investors on Wednesday, August 7 th , 2024, at 8:00 a.m. ET ...
2024-07-03 08:15:00 ET Some beaten-down stocks have significant upside potential and, therefore, present attractive buying opportunities for investors. However, other companies that are failing to keep pace with the market and are likely to keep struggling for a long time aren't worth inves...